TrueMark Investments »

Vaneck Vectors Pharmaceutical etf shares owned by TrueMark Investments

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by TrueMark Investments from 13F filings

Historical chart of TrueMark Investments investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by TrueMark Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by TrueMark Investments

Quarter filed Position value Share count Share price at filing
2025-03-31 $508k 5.6k 91.13

More positions owned by TrueMark Investments

Spdr Series Trust State Street Spd (SPSB)
Philip Morris International (PM)
MPLX Com Unit Rep Ltd (MPLX)
Verizon Communications (VZ)
Nextera Energy (NEE)
Citigroup Com New (C)
Elevation Series Trust Trueshares Struc
Elevation Series Trust Trueshares Strcd
Enbridge (ENB)
Novo-nordisk A S Adr (NVO)
British Amern Tob Sponsored Adr (BTI)
Elevation Series Trust Trueshares Struc
Elevation Series Trust Trueshares Struc
Goldman Sachs (GS)
Elevation Series Trust Trueshares Struc

View all positions for TrueMark Investments

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
UBS Group
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf